Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP751489.RADvw8PGHGSV_zuNzyN9J8HQgdb853N0u_xfH_GofpKJ8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP751489.RADvw8PGHGSV_zuNzyN9J8HQgdb853N0u_xfH_GofpKJ8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP751489.RADvw8PGHGSV_zuNzyN9J8HQgdb853N0u_xfH_GofpKJ8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP751489.RADvw8PGHGSV_zuNzyN9J8HQgdb853N0u_xfH_GofpKJ8130_provenance.
- NP751489.RADvw8PGHGSV_zuNzyN9J8HQgdb853N0u_xfH_GofpKJ8130_assertion description "[In this context, the distinctive role of a positive JAK2(V617F) mutation for the diagnosis of Ph- MPD was underscored, including entities with a low allele burden and the discrimination from reactive disorders (autoimmune myelofibrosis, reactive thrombocytosis).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751489.RADvw8PGHGSV_zuNzyN9J8HQgdb853N0u_xfH_GofpKJ8130_provenance.
- NP751489.RADvw8PGHGSV_zuNzyN9J8HQgdb853N0u_xfH_GofpKJ8130_assertion evidence source_evidence_literature NP751489.RADvw8PGHGSV_zuNzyN9J8HQgdb853N0u_xfH_GofpKJ8130_provenance.
- NP751489.RADvw8PGHGSV_zuNzyN9J8HQgdb853N0u_xfH_GofpKJ8130_assertion SIO_000772 19605821 NP751489.RADvw8PGHGSV_zuNzyN9J8HQgdb853N0u_xfH_GofpKJ8130_provenance.
- NP751489.RADvw8PGHGSV_zuNzyN9J8HQgdb853N0u_xfH_GofpKJ8130_assertion wasDerivedFrom befree-2016 NP751489.RADvw8PGHGSV_zuNzyN9J8HQgdb853N0u_xfH_GofpKJ8130_provenance.
- NP751489.RADvw8PGHGSV_zuNzyN9J8HQgdb853N0u_xfH_GofpKJ8130_assertion wasGeneratedBy ECO_0000203 NP751489.RADvw8PGHGSV_zuNzyN9J8HQgdb853N0u_xfH_GofpKJ8130_provenance.
- befree-2016 importedOn "2016-02-19" NP751489.RADvw8PGHGSV_zuNzyN9J8HQgdb853N0u_xfH_GofpKJ8130_provenance.